Patents
 

Cumulative list of patents dating from July 1991. Developments occurring in 2002/03 year are in green bold typeface. Abandoned applications shown in blue.
 
Cytokine-like molecule and bioassay therefore. ( Patent Description ) A novel tyrosine kinase and uses thereof
A method for regulating neuron development and maintenance Leukaemia inhibitory factor-binding protein
A novel neurogenic growth factor Monoclonal antibody
A Novel Protein Tyrosine Kinase An Immunoreactive molecule which binds the Tie2/Tek receptor extracellular domain
Receptor-binding determinant from Leukaemia Inhibitory Factor A method for identifying and cloning receptor ligands.
Modified cytokine receptors and components thereof A novel Haemopoietin receptor

 

A method for cloning haemopoietin receptor gene sequences A Novel Haemopoietin Receptor and Genetic Sequences Encoding Same
A Novel Haemopoietin Receptor and Genetic Sequences Encoding Same Novel Receptor Ligands and Genetic Sequences Encoding Same - I
Novel Receptor Ligands and Genetic Sequences Encoding Same - IIA A Novel Receptor-Type Tyrosine Kinase and Use Thereof
A Novel Haemopoietin Receptor and Genetic Sequences Encoding Same Therapeutic Molecules
A Method of Treatment A Method of Treatment and Prophylaxis
Therapeutic and Diagnostic Agents Novel chimeric molecules
Novel molecules and uses thereof-II A method of treatment and prophylaxis
Novel proteins, their derivatives, homologues and analogues and uses therefore Cell modulating agents

EGF receptor family ligands

A Method and agents useful for same
A Method and agents useful for same A Method of Treatment
Truncated EGF receptor A biologically active complex
A method for diagnosis and treatment Therapeutic and Diagnostic Molecules-II
Cytokine receptor Methods of screening based on the EGF receptor crystal structure
Therapeutic and Diagnostic Molecules Reproductive function modulating agents and uses therefore
Modulating cytokine and hormone signalling in animal comprising up regulating the expression of SOCS sequences in the animal. Differentiation and/or proliferation modulating agents and uses therefore
A method and agents useful for same A method and agents useful for same
Crystal structure of ErbB2 and uses thereof Novel Peptides
Therapeutic compositions Active compounds and uses thereof

top


The Cooperative Research Centre for Cellular Growth Factors. Disclaimer and Copyright Information.
 January 2004.